Literature DB >> 30143422

Identification of potent RORβ modulators: Scaffold variation.

Christelle Doebelin1, Rémi Patouret1, Ruben D Garcia-Ordonez1, Mi Ra Chang1, Venkatasubramanian Dharmarajan1, Scott Novick1, Anthony Ciesla1, Sean Campbell2, Laura A Solt2, Patrick R Griffin1, Theodore M Kamenecka3.   

Abstract

We sought to develop RORβ-selective probe molecules in order to investigate the function of the receptor in vitro and in vivo and its role in the pathophysiology of disease. To accomplish this, we modified a potent dual RORβ/RORγ inverse agonist from the primary literature with the goal of improving selectivity for RORβ vs RORγ. Truncation of the Western portion of the molecule ablated activity at RORγ and led to a potent series of RORβ modulators. Continued exploration of this series investigated alternate replacement cores for the aminothiazole ring. Numerous suitable replacements were found during the course of our SAR investigations and are reported herein.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aminothiophene; Nuclear receptor; RORβ; Selective ligand

Mesh:

Substances:

Year:  2018        PMID: 30143422      PMCID: PMC6238650          DOI: 10.1016/j.bmcl.2018.08.017

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  22 in total

1.  X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation.

Authors:  C Stehlin; J M Wurtz; A Steinmetz; E Greiner; R Schüle; D Moras; J P Renaud
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

Review 2.  Circadian genes, rhythms and the biology of mood disorders.

Authors:  Colleen A McClung
Journal:  Pharmacol Ther       Date:  2007-02-28       Impact factor: 12.310

3.  Novel small molecule bradykinin B2 receptor antagonists.

Authors:  Christoph Gibson; Karsten Schnatbaum; Jochen R Pfeifer; Elsa Locardi; Matthias Paschke; Ulf Reimer; Uwe Richter; Dirk Scharn; Alexander Faussner; Thomas Tradler
Journal:  J Med Chem       Date:  2009-07-23       Impact factor: 7.446

4.  Examination of nuclear receptor expression in osteoblasts reveals Rorβ as an important regulator of osteogenesis.

Authors:  Matthew M Roforth; Gang Liu; Sundeep Khosla; David G Monroe
Journal:  J Bone Miner Res       Date:  2012-04       Impact factor: 6.741

5.  A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice.

Authors:  D R Shalinsky; E D Bischoff; W W Lamph; L Zhang; M F Boehm; P J Davies; A M Nadzan; R A Heyman
Journal:  Cancer Res       Date:  1997-01-01       Impact factor: 12.701

6.  staggerer phenotype in retinoid-related orphan receptor alpha-deficient mice.

Authors:  M Steinmayr; E André; F Conquet; L Rondi-Reig; N Delhaye-Bouchaud; N Auclair; H Daniel; F Crépel; J Mariani; C Sotelo; M Becker-André
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

7.  Disruption of the nuclear hormone receptor RORalpha in staggerer mice.

Authors:  B A Hamilton; W N Frankel; A W Kerrebrock; T L Hawkins; W FitzHugh; K Kusumi; L B Russell; K L Mueller; V van Berkel; B W Birren; L Kruglyak; E S Lander
Journal:  Nature       Date:  1996-02-22       Impact factor: 49.962

8.  Retinoid-related orphan nuclear receptor RORbeta is an early-acting factor in rod photoreceptor development.

Authors:  Li Jia; Edwin C T Oh; Lily Ng; Maya Srinivas; Matthew Brooks; Anand Swaroop; Douglas Forrest
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-24       Impact factor: 11.205

9.  Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.

Authors:  Christian Gege; Thomas Schlüter; Thomas Hoffmann
Journal:  Bioorg Med Chem Lett       Date:  2014-09-28       Impact factor: 2.823

10.  Identification of an allosteric binding site for RORγt inhibition.

Authors:  Marcel Scheepstra; Seppe Leysen; Geert C van Almen; J Richard Miller; Jennifer Piesvaux; Victoria Kutilek; Hans van Eenennaam; Hongjun Zhang; Kenneth Barr; Sunil Nagpal; Stephen M Soisson; Maria Kornienko; Kristen Wiley; Nathaniel Elsen; Sujata Sharma; Craig C Correll; B Wesley Trotter; Mario van der Stelt; Arthur Oubrie; Christian Ottmann; Gopal Parthasarathy; Luc Brunsveld
Journal:  Nat Commun       Date:  2015-12-07       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.